Entia Biosciences Inc. announced the resignation of Carl J. Johnson from his positions as President, Chief Executive Officer and as a member of the company's Board of Directors. The company's Board of Directors has appointed Timothy A. Timmins as President and Chief Executive Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -.--% | -.--% | -.--% |
2017 | Entia Biosciences, Inc. Announces Management Changes | CI |
2017 | Entia Biosciences, Inc Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.41K | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ERGO Stock
- News Entia Biosciences, Inc.
- Entia Biosciences, Inc. Announces Management Changes